Plexus Corp (PLXS) Director Awarded Restricted Stock Units
PLEXUS CORP
Subscribe to track PLXS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Plexus Corp (PLXS) Director Awarded Restricted Stock Units
Company: PLEXUS CORP (PLXS) Form: 4/A | Filed: 2025-11-03 Significance: Low
Insider: Wuamett Jennifer Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 1,370 (Restricted Stock Units) • Price: $0.00 • Value: $0 • Owned After: 1,370 RSUs
Key Insight: A routine grant of Restricted Stock Units (RSUs) to a director as part of their compensation. The number of shares is negligible compared to total shares outstanding.
Market Context: This Form 4/A amends a previous filing to correct the number of RSUs granted. Such grants are standard practice for director compensation and have a minimal immediate market impact.
Comprehensive Analysis
SEC Filing Analysis: PLEXUS CORP (PLXS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director was granted 1,370 Restricted Stock Units (RSUs) as part of a standard compensation package. This amended filing corrects the number of units from a previous report.
- Market Impact: Neutral. This is a routine, non-market transaction with negligible impact on share dilution.
Company Information
| Field | Value |
|---|---|
| Company | PLEXUS CORP |
| Ticker Symbol | PLXS |
| CIK | 0000785786 |
| Industry | PRINTED CIRCUIT BOARDS [3672] |
Insider Information
| Field | Value |
|---|---|
| Name | Wuamett Jennifer |
| CIK | 0001597265 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A |
| Transaction Date | 2025-02-03 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 1370 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 1370 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 1,370 |
| % of Shares Outstanding | 0.005% |
| Post-Transaction Ownership | 1,370 RSUs (0.005% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has no market value and is insignificant against the company's $3.78 billion market capitalization.
- Ownership Concentration: The grant establishes a small initial holding for the director, representing a negligible percentage of total shares outstanding.
- Dilution Impact: The potential dilution from these 1,370 shares is extremely low (0.005%), posing no material impact to existing shareholders.
- Transaction Significance: This is a routine compensatory grant to a non-executive director. The filing is an amendment to correct a prior report, further reducing its significance as new market information. The transaction size is well below any threshold for materiality.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market transaction representing standard director compensation. It does not signal any change in the insider's view of the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market transaction and will not directly influence trading volume.
- Sentiment Indicator: Neutral. The market generally views such routine grants as a standard cost of business.
Additional Context
Transaction Notes
- Footnote Details: The Restricted Stock Units were granted under the Plexus Corp. 2024 Omnibus Incentive Plan and will vest on February 3, 2026. Each RSU represents a contingent right to receive one share of common stock.
- Special Circumstances: This is a Form 4/A, filed to amend a previous Form 4 from 2025-02-05 to correct the number of RSUs granted.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
